These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1648996)

  • 61. Flow cytometric analysis of DNA ploidy in hepatocellular carcinoma.
    Ng IO; Lai EC; Ho JC; Cheung LK; Ng MM; So MK
    Am J Clin Pathol; 1994 Jul; 102(1):80-6. PubMed ID: 8037171
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients.
    Lewis WE
    Cancer; 1990 May; 65(10):2315-20. PubMed ID: 2346915
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Flow cytometric analysis of nuclear DNA from adrenocortical neoplasms. A retrospective study using paraffin-embedded tissue.
    Amberson JB; Vaughan ED; Gray GF; Naus GJ
    Cancer; 1987 Jun; 59(12):2091-5. PubMed ID: 3567870
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma.
    Volm M; Hahn EW; Mattern J; Müller T; Vogt-Moykopf I; Weber E
    Cancer Res; 1988 May; 48(10):2923-8. PubMed ID: 2834052
    [TBL] [Abstract][Full Text] [Related]  

  • 65. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
    del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
    Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Flow cytometric DNA analysis of hepatocellular carcinoma.
    Fujimoto J; Okamoto E; Yamanaka N; Toyosaka A; Mitsunobu M
    Cancer; 1991 Feb; 67(4):939-44. PubMed ID: 1846770
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The relevance of flow-cytometric DNA content in the evaluation of lung cancer.
    Salvati F; Teodori L; Trinca ML; Pasquali-Lasagni R; Göhde W
    J Cancer Res Clin Oncol; 1994; 120(4):233-9. PubMed ID: 8288677
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Flow cytometry as a tool for the prognostic assessment of patients with lung and ovarian carcinomas.
    Volm M; Drings P; Kleine W; Mattern J
    Strahlenther Onkol; 1987 Dec; 163(12):791-4. PubMed ID: 2827331
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Proliferative activity assessed on the basis of DNA ploidy patterns in primary lung cancer].
    Yamaoka N; Tagawa Y; Miyashita K; Ayabe H; Kawahara K; Uchiyama Y; Tomita M
    Nihon Geka Gakkai Zasshi; 1991 May; 92(5):598-602. PubMed ID: 1875901
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic implications of DNA histogram, DNA content, and histologic changes of regional lymph nodes in patients with lung cancer.
    Ogawa J; Iwazaki M; Tsurumi T; Inoue H; Shohtsu A
    Cancer; 1991 Mar; 67(5):1370-6. PubMed ID: 1991300
    [TBL] [Abstract][Full Text] [Related]  

  • 72. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
    Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
    Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Flow cytometric DNA analysis of advanced prostatic adenocarcinoma.
    Wu WJ; Huang MS; Wang HJ; Chiang PH; Huang CH; Chiang CP
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Mar; 9(3):122-30. PubMed ID: 8510195
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Contribution of flow cytometry in the prognostic evaluation of non-small-cell lung cancers. Review of the literature].
    Jeanfaivre T; Chassevent A; Larra F; Tuchais E
    Bull Cancer; 1994 Jul; 81(7):605-9. PubMed ID: 7742603
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A comparison of flow and image DNA cytometry in prediction of patient prognosis in surgically resected small cell lung cancer.
    Carey FA; Gray E; O'Mahony M; Craig SR; Salto-Tellez M; Lamb D
    Anal Cell Pathol; 1996 Dec; 12(3):137-43. PubMed ID: 9025990
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic significance of DNA content in large bowel carcinoma: a retrospective flow cytometric study.
    Scivetti P; Danova M; Riccardi A; Fiocca R; Dionigi P; Mazzini G
    Cancer Lett; 1989 Aug; 46(3):213-9. PubMed ID: 2766261
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic significance of flow cytometry in lung cancer. A 5-year study.
    Tirindelli-Danesi D; Teodori L; Mauro F; Modini C; Botti C; Cicconetti F; Stipa S
    Cancer; 1987 Aug; 60(4):844-51. PubMed ID: 3594402
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Survival of rectal carcinoma patients studied with flow cytometric DNA analysis.
    Araki Y; Isomoto H; Morodomi T; Shirouzu K; Kakegawa T
    Kurume Med J; 1990; 37(4):277-83. PubMed ID: 2097445
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Flow-cytometric prognostic factors for the survival of patients with ovarian carcinoma: a 5-year follow-up study.
    Volm M; Kleine W; Pfleiderer A
    Gynecol Oncol; 1989 Oct; 35(1):84-9. PubMed ID: 2792909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.